Oscar Health, Inc. reports news on its healthcare technology business, which uses a full-stack platform to offer Individual & Family health plans, ICHRA solutions, +Oscar technology services and the Lucie Health Marketplace. Company updates commonly cover quarterly financial results, medical loss ratio and expense metrics, guidance, membership trends and product expansion in the individual health insurance market.
Oscar Health announcements also include marketplace and plan launches, broker and employer-facing healthcare shopping tools, technology features, capital-structure activity and board governance changes. The company’s recurring news themes connect its insurance products, member experience and healthcare technology services to developments in ACA exchange markets and consumer-directed coverage.
Oscar Health (NYSE: OSCR) will release its third-quarter 2026 financial results before the market opens on November 5, 2026. Management will review the results on a conference call at 8:00 AM ET. A live audio webcast will be available, with a replay on the investor relations website shortly after the call for 90 days.
Oscar Health (OSCR) reported that on September 18, 2026, funds affiliated with majority stockholder Thrive Capital distributed about 6.3 million Class A shares to their limited partners as an in-kind return of capital, not a sale of Company shares by Thrive Capital or Joshua Kushner.
Joshua Kushner will remain Vice Chair and controlling shareholder and has informed the Company he has no plans to sell any personally held Oscar shares. After the distribution, Thrive Capital–affiliated entities, including Kushner, beneficially own about 4.7 million Class A shares and 32.9 million Class B shares, representing roughly 67% of Oscar’s combined voting power.
Oscar Health (NYSE: OSCR) reported strong second quarter and record first-half 2026 results and raised its full-year 2026 outlook. Q2 2026 total revenue rose to $4.9 billion from $2.9 billion, with medical loss ratio improving to 79.2% from 91.1% and SG&A expense ratio to 14.2% from 18.7%.
Q2 earnings from operations were $388.6 million versus a loss of $230.5 million a year earlier, and net income attributable to Oscar was $361.8 million versus a $228.4 million loss. First-half 2026 earnings from operations reached $1.09 billion and net income $1.04 billion. Membership grew to 2.96 million from 2.03 million.
For full-year 2026, Oscar maintained revenue guidance of $18.7–$19.0 billion but increased expected earnings from operations to $500–$700 million from $250–$450 million, while tightening guidance for both MLR and SG&A expense ratios lower.
Oscar Health (NYSE: OSCR) will host its 2026 Investor Day on Wednesday, September 16, 2026, starting at 9:00 AM ET. Management plans to discuss corporate strategy, financial performance, and long-term financial targets. A live webcast and materials will be available and archived for 90 days on Oscar’s investor relations website.
Oscar Health (NYSE: OSCR) will release its second quarter 2026 financial results before the market opens on Thursday, August 6, 2026. Management will discuss the results on a conference call starting at 8:00 AM (ET), accessible via live call at (855) 761-5600 using Conference ID 7768132, and via webcast. An archived replay will be available on Oscar’s investor relations site (ir.hioscar.com) for 90 days following August 6, 2026.
Oscar Health (NYSE: OSCR) reported strong first-quarter 2026 results: total revenue $4.65B, net income $679.0M and Adjusted EBITDA $727.1M. Membership rose to 3.17M members and the medical loss ratio improved to 70.5%. The company reaffirmed full‑year 2026 guidance and will host a May 6, 2026 conference call.
Key drivers cited include higher membership, rate increases, favorable prior‑period reserve development, fixed cost leverage, and disciplined pricing.
Oscar Health (NYSE: OSCR) named independent director Siddhartha Sankaran as Chair of the Board, effective June 4, 2026. Sankaran succeeds Jeffery Boyd, who is not standing for reelection at the Annual Meeting. Sankaran has 20+ years of insurance leadership and five years on Oscar's board.
The appointment signals governance continuity with an experienced insurance executive leading the board through Oscar's next growth phase.
Oscar Health (NYSE: OSCR) launched Lucie Health Marketplace on April 20, 2026, an all-in-one storefront that integrates every major individual medical carrier with curated ancillary and supplemental products.
Lucie offers individual medical, dental, vision, accident, and hospital coverage, includes networks in almost all zip codes, and supports employers, brokers, and consumers with instant quoting, enrollment, and renewals.
Oscar Health (NYSE: OSCR) will release first quarter 2026 financial results before market open on Wednesday, May 6, 2026. Management will host a conference call at 8:00 AM ET to review results; a live call and webcast will be available and archived for 90 days.
Call-in: 1.855.761.5600, Conference ID: 7768132. The archived webcast will be posted on the investor relations website following May 6, 2026.
Oscar Health (NYSE: OSCR) reported fourth-quarter and full-year 2025 results and provided 2026 guidance. The company said it achieved a record membership of approximately 3.4 million and delivered $11.7 billion revenue for 2025, while reporting a $443.2 million net loss for the year. Oscar gave full‑year 2026 guidance of $18.7–$19.0 billion revenue and projected operating income of $250–$450 million. The company also closed a $475 million secured three‑year revolving credit facility on February 6, 2026.